Parkman Healthcare Partners LLC / RCUS
Parkman Healthcare Partners LLC’s Arcus Biosciences Inc Position
Does Parkman Healthcare Partners LLC own Arcus Biosciences Inc (RCUS)? Yes — 1.21M shares worth $26M (+2.69% of its 13F portfolio) as of Q1 2026, up from 968.6K shares the prior filed quarter.
Position Value
$26M
Q1 2026
Shares
1.21M
% of Portfolio
+2.69%
Quarters Held
24
currently held
Position History RCUS
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.21M | $26M | +2.69% |
| Q4 2025 | 968.6K | $23M | +2.20% |
| Q3 2025 | 652.7K | $9M | +0.93% |
| Q2 2025 | 599.6K | $5M | +0.56% |
| Q1 2025 | 1.22M | $10M | +1.13% |
| Q4 2024 | 1.27M | $19M | +2.53% |
| Q3 2024 | 1.03M | $16M | +2.00% |
| Q2 2024 | 415.5K | $6M | +0.85% |
| Q1 2024 | 259.9K | $5M | +0.60% |
| Q4 2023 | 247.7K | $5M | +0.67% |
| Q3 2023 | 205.1K | $4M | +0.67% |
| Q2 2023 | 120.0K | $2M | +0.42% |
| Q1 2023 | 103.0K | $2M | +0.41% |
| Q4 2022 | 87.5K | $2M | +0.48% |
| Q3 2022 | 137.9K | $4M | +1.03% |
| Q2 2022 | 171.2K | $4M | +1.60% |
| Q1 2022 | 167.3K | $5M | +1.55% |
| Q4 2021 | 117.1K | $5M | +1.05% |
| Q3 2021 | 236.6K | $8M | +2.09% |
| Q2 2021 | 246.6K | $7M | +1.48% |
| Q1 2021 | 315.9K | $9M | +2.06% |
| Q4 2020 | 231.8K | $6M | +1.54% |
| Q3 2020 | 235.0K | $4M | +1.07% |
| Q2 2020 | 160.0K | $4M | +1.12% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Parkman Healthcare Partners LLC’s full portfolio or all institutional holders of RCUS.